Similar Articles
Macular Degeneration and Treatment
Mine Ün, Sedef Öztürk
DOI: 10.5606/jebms.2020.75600
Issue: 2020, Volume 1 - Issue 1
1087
1106
Migraine and Calcitonin Gene-Related Peptide Receptor Antagonist Treatment
Yasemin Akbaş
DOI: 10.5606/jebms.2020.75617
Issue: 2020, Volume 1 - Issue 2
983
974
Familial Autism Genes
Ezgi Seda Yayla
DOI: 10.5606/jebms.2020.75621
Issue: 2020, Volume 1 - Issue 3
1109
1049
What Does CRISPR Technology Provide to Cancer Treatments?
Güner Yaman, Nilsu Çini, İlknur Altuntaş, Oytun Erbaş
DOI: 10.5606/jebms.2021.75637
Issue: 2021, Volume 2 - Issue 1
1288
780
Multiple Myeloma Treatment
Edanur Tekin, Özge Çağlar, Elif Özyılmaz, Oytun Erbaş
DOI: 10.5606/jebms.2021.75658
Issue: 2021, Volume 2 - Issue 2
651
582
Metformin as Cancer Preventative and Therapeutic Agent
İlayda Üzümcü, Burak Akverdi, Elif Ünaldı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1006
Issue: 2022, Volume 3 - Issue 1
909
548
Depression and Cardiovascular Disease: A Mutual Relationship
Bahar Işık,Oytun Erbaş
DOI: 10.5606/jebms.2023.1041
Issue: 2023, Volume 4 - Issue 1
491
535
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Issue: 2023, Volume 4 - Issue 2
510
462
Revolutionizing Health Technologies: The Transformative Power of Stem Cells
Tutku Özaydın, Kerem Can Tunç, Oytun Erbaş
DOI: 10.5606/jebms.2024.1071
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
308
323
Stem Cell Applications: A Promising Future for Autoimmune Diseases?
Öznur Safgöl, Oytun Erbaş
DOI: 10.5606/jebms.2024.1075
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
298
328
Stem Cells in Surgery
Buse Kaptan, Oytun Erbaş
DOI: 10.5606/jebms.2024.1080
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
300
267
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
385
289